These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23409765)

  • 1. Impact of quaternary structure dynamics on allosteric drug discovery.
    Jaffe EK
    Curr Top Med Chem; 2013; 13(1):55-63. PubMed ID: 23409765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphobilinogen synthase: An equilibrium of different assemblies in human health.
    Jaffe EK
    Prog Mol Biol Transl Sci; 2020; 169():85-104. PubMed ID: 31952692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allostery and the dynamic oligomerization of porphobilinogen synthase.
    Jaffe EK; Lawrence SH
    Arch Biochem Biophys; 2012 Mar; 519(2):144-53. PubMed ID: 22037356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Remarkable Character of Porphobilinogen Synthase.
    Jaffe EK
    Acc Chem Res; 2016 Nov; 49(11):2509-2517. PubMed ID: 27783504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins).
    Tang L; Breinig S; Stith L; Mischel A; Tannir J; Kokona B; Fairman R; Jaffe EK
    J Biol Chem; 2006 Mar; 281(10):6682-90. PubMed ID: 16377642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morpheeins--a new structural paradigm for allosteric regulation.
    Jaffe EK
    Trends Biochem Sci; 2005 Sep; 30(9):490-7. PubMed ID: 16023348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking to large allosteric binding sites on protein surfaces.
    Ramirez UD; Myachina F; Stith L; Jaffe EK
    Adv Exp Med Biol; 2010; 680():481-8. PubMed ID: 20865533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric inhibition of human porphobilinogen synthase.
    Lawrence SH; Ramirez UD; Selwood T; Stith L; Jaffe EK
    J Biol Chem; 2009 Dec; 284(51):35807-17. PubMed ID: 19812033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.
    Jaffe EK; Stith L; Lawrence SH; Andrake M; Dunbrack RL
    Arch Biochem Biophys; 2013 Feb; 530(2):73-82. PubMed ID: 23296088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic dissociating homo-oligomers and the control of protein function.
    Selwood T; Jaffe EK
    Arch Biochem Biophys; 2012 Mar; 519(2):131-43. PubMed ID: 22182754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate-induced interconversion of protein quaternary structure isoforms.
    Tang L; Stith L; Jaffe EK
    J Biol Chem; 2005 Apr; 280(16):15786-93. PubMed ID: 15710608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical characterization of full-length human phenylalanine hydroxylase provides a deeper understanding of its quaternary structure equilibrium.
    Arturo EC; Gupta K; Hansen MR; Borne E; Jaffe EK
    J Biol Chem; 2019 Jun; 294(26):10131-10145. PubMed ID: 31076506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The morpheein model of allostery: evaluating proteins as potential morpheeins.
    Jaffe EK; Lawrence SH
    Methods Mol Biol; 2012; 796():217-31. PubMed ID: 22052493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shape shifting leads to small-molecule allosteric drug discovery.
    Lawrence SH; Ramirez UD; Tang L; Fazliyez F; Kundrat L; Markham GD; Jaffe EK
    Chem Biol; 2008 Jun; 15(6):586-96. PubMed ID: 18559269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MORPHEEINS - A NEW PATHWAY FOR ALLOSTERIC DRUG DISCOVERY.
    Jaffe EK
    Open Conf Proc J; 2010; 1():1-6. PubMed ID: 21643557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the identification of the allosteric Phe-binding site in phenylalanine hydroxylase.
    Carluccio C; Fraternali F; Salvatore F; Fornili A; Zagari A
    J Biomol Struct Dyn; 2016; 34(3):497-507. PubMed ID: 26479306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALAD porphyria is a conformational disease.
    Jaffe EK; Stith L
    Am J Hum Genet; 2007 Feb; 80(2):329-37. PubMed ID: 17236137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.
    Kokona B; Rigotti DJ; Wasson AS; Lawrence SH; Jaffe EK; Fairman R
    Biochemistry; 2008 Oct; 47(40):10649-56. PubMed ID: 18795796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.